Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-02 Sale | 2023-03-03 5:09 pm | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 75,000 | $85.46 | $6,409,473 | 881,754 (Indirect Direct) | View |
| 2020-11-09 Sale | 2020-11-10 5:43 pm | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 81,657 | $175.01 | $14,291,048 | 28,166 (Indirect Direct) | View |
| 2019-09-27 Sale | 2019-09-30 3:18 pm | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 63,000 | $86.61 | $5,456,115 | 109,823 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-26 Disposition | 2023-09-26 4:30 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 1,203,010 | $0 | 0 (Direct) | View |
| 2023-07-06 Option Award | 2023-07-10 4:38 pm | N/A 2032-09-29 | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 359,656 | $0 | 1,203,010 (Direct) | View |
| 2023-03-01 Conversion | 2023-03-03 5:09 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 75,000 | $0 | 881,754 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 5:35 pm | N/A 2033-01-03 | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 237,975 | $0 | 1,743,517 (Direct) | View |
| 2020-12-22 Ownership | 2021-01-06 5:14 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 270,000 | $0 | 2,036,748 (Direct) | View |
Ownership | 2021-01-06 5:14 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 0 | $0 | 2,036,748 (Indirect) | View |
| 2021-01-04 Option Award | 2021-01-06 4:38 pm | N/A 2031-01-04 | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 44,600 | $0 | 1,505,542 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 2:56 pm | N/A 2030-01-02 | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2019-10-14 Option Award | 2019-11-12 5:27 pm | N/A 2029-01-02 | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 114,500 | $0 | 114,500 (Direct) | View |
| 2019-09-23 Gift | 2019-09-30 3:18 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 19,500 | $0 | 109,823 (Direct) | View |